Tuning cell behavior with nanoparticle shape

PLoS One. 2020 Nov 13;15(11):e0240197. doi: 10.1371/journal.pone.0240197. eCollection 2020.

Abstract

We investigated how the shape of polymeric vesicles, made by the exact same material, impacts the replication activity and metabolic state of both cancer and non-cancer cell types. First, we isolated discrete geometrical structures (spheres and tubes) from a heterogeneous sample using density-gradient centrifugation. Then, we characterized the cellular internalization and the kinetics of uptake of both types of polymersomes in different cell types (either cancer or non-cancer cells). We also investigated the cellular metabolic response as a function of the shape of the structures internalized and discovered that tubular vesicles induce a significant decrease in the replication activity of cancer cells compared to spherical vesicles. We related this effect to the significant up-regulation of the tumor suppressor genes p21 and p53 with a concomitant activation of caspase 3/7. Finally, we demonstrated that combining the intrinsic shape-dependent effects of tubes with the delivery of doxorubicin significantly increases the cytotoxicity of the system. Our results illustrate how the geometrical conformation of nanoparticles could impact cell behavior and how this could be tuned to create novel drug delivery systems tailored to specific biomedical application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caspase 3 / genetics
  • Caspase 7 / genetics
  • Cell Line, Tumor
  • Centrifugation, Density Gradient
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • DNA Replication / drug effects
  • Doxorubicin / pharmacology*
  • HeLa Cells
  • Humans
  • Nanoparticles / classification*
  • Nanoparticles / ultrastructure
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Tumor Suppressor Protein p53 / genetics
  • Up-Regulation / drug effects*

Substances

  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Doxorubicin
  • CASP3 protein, human
  • CASP7 protein, human
  • Caspase 3
  • Caspase 7

Associated data

  • Dryad/10.5061/dryad.2bvq83bp1

Grants and funding

We are grateful to Children with Cancer UK, ERC starting grant MEVIC: 278793 and EPSRC (EP/N026322/1) to sponsor the salary and the work of E.S., C.D.P., A.S.J., S.C.D.S., E.L.D., C.C., G.B, and L.R.; We thank British Technology Group (BTG) for donating the MPC monomer; G.B. and E.S. thank Children with Cancer UK for funding; S.C.D.S. thanks Astrazeneca for covering part of the stipend; V.D.M. kindly acknowledges Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014-2020 Asse I “Capitale Umano”, Azione I.2, Avviso “A.I.M: Attraction and International Mobility” CUP F88D18000070001. L.R. sincerely thanks the Marie Sklodowska-Curie actions PHANTOM (795224) for supporting part of his research activities, the ERC-2019-STG (grant number: 850936) and the Fondazione Cariplo (grant number 2019-4278) to sponsor the salary and this work. The specific roles of these authors are articulated in the ‘author contributions’ section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.